Company: NCEL
Filing Date: 2025-02-10
Form Type: F-3
Source: 0001213900-25-011823
Chunk: 0

Company: NewcelX Ltd.
Filing Date: 2025-02-10
Form: F-3
Chunk 0
---
<div align='center'>As filed with the Securities and Exchange Commission on February 10, 2025</div>

Registration No. 333-

<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM F-3

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

NLS Pharmaceutics Ltd.

(Exact name of registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s Name into English)</div>

| Switzerland                     |     | Not Applicable     |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -I.R.S. Employer   
 Identification No. |

| The Circle 6             |
| 8058 Zurich, Switzerland |

<div align='center'>+41.44.512.2150

(Address and telephone number of registrant’s
principal executive offices)

Puglisi & Associates</div>

| 850 Library Ave., Suite 204 |
| Newark, DE 19711            
 Tel: (302) 738-6680         |

<div align='center'>(Name, address, and telephone number of agent for
service)

Copies to:</div>

| Oded Har-Even, Esq.         
 Howard Berkenblit, Esq.     
 Sullivan & Worcester LLP    
 1251 Avenue of the Americas 
 New York, NY 10020          
 Tel: 212.660.3000           |     | Dr. Matthias Courvoisier      
 Baker McKenzie Switzerland AG 
 Holbeinstrasse 30             
 Zurich, Switzerland 8034      
 Tel: +41 44 384 14 14         |

Approximate date of commencement of proposed sale to the public: From time to time after the effective date hereof.

If the only securities being registered on this
Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐

If any of the securities being registered on this
Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, check the following box. ☒

If this Form is filed to register additional securities
for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed
pursuant to